Europe Takes Bold Step: Biannual HIV Prevention Injection Approved as Cases Surge
Image Credit: vilma3000/123rf.com The European Commission has approved the first twice-yearly injection for HIV prevention, marking a significant advancement in public health. The drug, lenacapavir, marketed as Yeytuo, has demonstrated 100 percent effectiveness in preventing HIV transmission during clinical trials. This breakthrough is expected to enhance accessibility, as it reduces the need for daily medication…
